American Society of Gene & Cell Therapy (ASGCT) Symposium: Genetic Engineering of T Cells
Chairs:
Michel Sadelain, Memorial Sloan Kettering Cancer Center
Stanley Riddell, Fred Hutchinson Cancer Research Center
Speakers:
Michel Sadelain, Memorial Sloan Kettering Cancer Center, Genetic engineering of chimeric antigen receptors
Jo Brewer, Adaptimmune LLC, T cell receptors
Stanley Riddell, Fred Hutchinson Cancer Research Center, What is the best T cell subset?
Ann M. Leen, Baylor College of Medicine, Genetically modified virus-specific cells